VCCC Annual Report 2019-20
The VCCC Annual Report 2019-20 highlights the breadth, diversity, and significance of the alliance's work, the potential for future growth, and the impact on the Victorian community.
The VCCC has partnered with Monash Partners Comprehensive Cancer consortium on a joint initiative to support clinicians and health care services treating patients with cancer during the COVID-19 pandemic and the recovery phase.
The Victorian COVID-19 Cancer Network (VCCN) provides a variety of resources and opportunities to get involved, learn and contribute.
There are two ways to get involved:
Subscribe to receive the VCCN newsletter with latest news, developments and changes to cancer care in Victoria, online events and seminars.
Become a VCCN Member: Health care workers can become a member of the VCCN and participate in online conversations and knowledge sharing via the VCCN Slack workspace. Members must agree to the terms and conditions to join.
Peter Mac is Australia’s only integrated cancer research, treatment and education centre, with multidisciplinary teams that provide care informed by precision in fundamental, translational and clinical research.
The Royal Melbourne Hospital (Melbourne Health) provides high-quality cancer treatment programs, translational research, and surgical and medical expertise, as well as other key support services such as clinical care and emergency medicine.
Australia’s first ranked research university and medical school, the university provides academic and research expertise to the alliance.
The Women’s provides specialist cancer services for women with breast and gynecological cancer and conducts research into the treatment and care of women with cancer, as well as the specific impacts of gender on cancer.
WEHI is one of Australia’s leading biomedical research organisations, with a strong national and international reputation for performing highly influential basic and translational research.
The Children’s Cancer Centre is the only provider of complex children’s cancer care and stem cell transplantation in Victoria and is a leader in the research and treatment of childhood cancer.
Western Health is the largest provider of treatment for colorectal cancer and a leader in the treatment of upper gastro-intestinal cancers with programs in breast, lung, genitourinary, gynaecology and haematological cancer.
Western Health has on-site radiation therapy and chemotherapy facilities and has a strong palliative care service.
A leader in palliative care practice and complex cancer surgery, St Vincent’s Hospital Melbourne also provides oncology and haematology services, on-site radiation therapy and chemotherapy facilities, in addition the hospital houses the Victorian-wide psycho-oncology service.
The hospital shares its campus with St Vincent's Institute, which has fundamental and clinical researchers working on mechanisms of cancer and diseases of cancer survivorship.
The Olivia Newton-John Cancer Wellness & Research Centre at Austin Health provides world-leading specialist treatment and holistic care including clinical trials both independently and in partnership with the Olivia Newton-John Cancer Research Institute (ONJCRI) – a leader in the development of experimental and breakthrough cancer treatments only metres from where patients are cared for.
The MCRI is a leader in understanding the underlying mechanisms and treatment of paediatric cancer and is home to the Children’s Cancer Tissue bank; a world class resource for researchers studying rare solid tumours and leukemia.
Peter Mac is Australia’s only integrated cancer research, treatment and education centre, with multidisciplinary teams that provide care informed by precision in fundamental, translational and clinical research.
The Royal Melbourne Hospital (Melbourne Health) provides high-quality cancer treatment programs, translational research, and surgical and medical expertise, as well as other key support services such as clinical care and emergency medicine.
Australia’s first ranked research university and medical school, the university provides academic and research expertise to the alliance.
The Women’s provides specialist cancer services for women with breast and gynecological cancer and conducts research into the treatment and care of women with cancer, as well as the specific impacts of gender on cancer.
WEHI is one of Australia’s leading biomedical research organisations, with a strong national and international reputation for performing highly influential basic and translational research.
The Children’s Cancer Centre is the only provider of complex children’s cancer care and stem cell transplantation in Victoria and is a leader in the research and treatment of childhood cancer.
Western Health is the largest provider of treatment for colorectal cancer and a leader in the treatment of upper gastro-intestinal cancers with programs in breast, lung, genitourinary, gynaecology and haematological cancer.
Western Health has on-site radiation therapy and chemotherapy facilities and has a strong palliative care service.
A leader in palliative care practice and complex cancer surgery, St Vincent’s Hospital Melbourne also provides oncology and haematology services, on-site radiation therapy and chemotherapy facilities, in addition the hospital houses the Victorian-wide psycho-oncology service.
The hospital shares its campus with St Vincent's Institute, which has fundamental and clinical researchers working on mechanisms of cancer and diseases of cancer survivorship.
The Olivia Newton-John Cancer Wellness & Research Centre at Austin Health provides world-leading specialist treatment and holistic care including clinical trials both independently and in partnership with the Olivia Newton-John Cancer Research Institute (ONJCRI) – a leader in the development of experimental and breakthrough cancer treatments only metres from where patients are cared for.
The MCRI is a leader in understanding the underlying mechanisms and treatment of paediatric cancer and is home to the Children’s Cancer Tissue bank; a world class resource for researchers studying rare solid tumours and leukemia.
2020 a year half empty or half full?
For some, it may feel as though we can put some distance between the uncertainty of 2020 as we enjoy current freedoms. These past weeks, I’ve heard many people say that they didn’t fully appreciate how deeply they had been affected by the events of last year and it’s taken time to process all that has occurred.
According to Vincent Dumez, Centre of Excellence on Partnership with Patients and the Public, the University of Montreal, we are in the middle of a patient-led innovation revolution. Does that make the 800 people who attended the first joint Australian and New Zealand Consumer Experience and Leadership in Health Summit last month revolutionaries?
Learn moreIt has been a long year for the 2020 Picchi Award winners who finally received their trophies last week. Matthew Grant is in the Netherlands experiencing the global pandemic from a European perspective. French-national Deborah Meyran completed her PhD with a young family, has forged new frontiers with her research, and France is suddenly much further away. Stefan Bjelosevic has been bunkered down at Peter Mac at the Johnstone Lab as a key member of the team. These young enterprising scientists have adapted to all that has been thrown at them, and this makes them even more impressive.
Learn moreNew online course endorsed by clinicians and consumers
Ray Kelly, Chair of the North Eastern Melbourne Integrated Cancer Service Consumer Reference Group and a member of the NEMICS Governance Committee recently road-tested a new, four-week, part-time massive open online course, Cancer and the Older Person, earning a certificate of achievement and giving it the thumbs up.
Cancer can be devastating in all its forms. There may be much to mourn. Head and neck cancers can be among the most distressing, not only for their obvious ability to alter a person’s appearance but for their capacity to affect a person’s sense of self.
It is rare for oncologists to receive training in the impacts of head and neck cancer and the effect that treatments may have on intimacy and sexual health. Yet we know that patients want to talk about sexual issues with oncologists, and they need practical information about changes in their sex life and reassurance that their issues are not unique.
Hosted by course convenors Professor Grant McArthur and Dr David Kok, along with research supervisors, this special virtual event will showcase the inaugural cohort of Master of Cancer Sciences alumni and their cancer research projects.
Invasive lobular carcinoma (ILC) of the breast – it's more heterogeneous than we think
ILC is the most commonly diagnosed histological type of breast cancer. Tumours have a characteristic dis-cohesive and invasive growth pattern that is underpinned by mutational inactivation of the CDH1 (E-cadherin) gene.
Please join VCCC Research and Education Lead, Dr Belinda Yeo, who will lead May’s masterclass focussing on treatment options in oligometastatic breast cancer (OMBC).
With the ongoing objective of enhancing relationships across the Victorian Comprehensive Cancer Centre (VCCC) alliance members, this position is offered as a secondment opportunity from within a member organisation to join the VCCC’s expert distributed leadership team.
The primary purpose of the VCCC Research Translation and Commercialisation Lead is to provide expert advice to VCCC and to support relevant VCCC programs within the research portfolio. The role will support research translation and commercialisation, the acceleration of novel therapies to the clinic, and clinical trial innovation within the VCCC alliance in order to ensure optimal program implementation leading to downstream improvement in patient outcomes.
The flexible program is designed to be of interest to PhD students with either a scientific or clinical background, including medical graduates, nursing and allied health specialists.